MannKind | MNKD - Trade Debtors


MannKind reported $38.37M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Adma Biologics USD 137.67M 27.94M Sep/2025
BioCryst Pharmaceuticals USD 79.07M 6.61M Dec/2024
Eli Lilly USD 19.46B 2.25B Sep/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
MacroGenics USD 69.23M 56.7M Sep/2025
MannKind USD 38.37M 20.98M Dec/2025
Merck USD 12.12B 596M Sep/2025
Novavax USD 94.96M 62.81M Sep/2024
Novo Nordisk DKK 14.27B 72.1B Jun/2025
Pfizer USD 18.12B 2.02B Sep/2025
Sanofi EUR 397M 100M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025